Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and cinnarizine

ezetimibe has been researched along with cinnarizine in 2 studies

Compound Research Comparison

Studies
(ezetimibe)		Trials
(ezetimibe)		Recent Studies (post-2010)
(ezetimibe)		Studies
(cinnarizine)		Trials
(cinnarizine)		Recent Studies (post-2010) (cinnarizine)
2,4845631,465855148190

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)cinnarizine (IC50)
Aldo-keto reductase family 1 member B1Rattus norvegicus (Norway rat)2.832
Muscarinic acetylcholine receptor M4Homo sapiens (human)3.66
Muscarinic acetylcholine receptor M5Homo sapiens (human)0.759
Alpha-2A adrenergic receptorHomo sapiens (human)0.444
Muscarinic acetylcholine receptor M1Homo sapiens (human)2.513
D(2) dopamine receptorHomo sapiens (human)0.776
Alpha-2B adrenergic receptorHomo sapiens (human)2.242
Alpha-2C adrenergic receptorHomo sapiens (human)0.652
5-hydroxytryptamine receptor 1ARattus norvegicus (Norway rat)1.083
Muscarinic acetylcholine receptor M3Homo sapiens (human)0.762
Sodium-dependent noradrenaline transporter Homo sapiens (human)2.832
Alpha-1D adrenergic receptorHomo sapiens (human)1.167
5-hydroxytryptamine receptor 2AHomo sapiens (human)0.36
5-hydroxytryptamine receptor 1BRattus norvegicus (Norway rat)1.083
Sodium-dependent serotonin transporterHomo sapiens (human)1.09
Histamine H1 receptorHomo sapiens (human)0.074
Mu-type opioid receptorHomo sapiens (human)2.272
D(3) dopamine receptorHomo sapiens (human)0.252
5-hydroxytryptamine receptor 2BHomo sapiens (human)0.731
Sodium-dependent dopamine transporter Homo sapiens (human)1.641
Sigma non-opioid intracellular receptor 1Homo sapiens (human)0.04

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Charman, WN; Porter, CJ; Quach, T; Trevaskis, NL; Tso, P; Yeap, YY1

Other Studies

2 other study(ies) available for ezetimibe and cinnarizine

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Intestinal bile secretion promotes drug absorption from lipid colloidal phases via induction of supersaturation.
    Molecular pharmaceutics, 2013, May-06, Volume: 10, Issue:5

    Topics: Administration, Oral; Animals; Azetidines; Bile; Biological Availability; Chemistry, Pharmaceutical; Cinnarizine; Colloids; Ezetimibe; Intestinal Absorption; Lipids; Male; Micelles; Models, Biological; Monensin; Permeability; Rats; Rats, Sprague-Dawley; Solubility; Thermodynamics

2013